0RAF Stock Overview

Designs, develops, and markets products for orthopedic surgery in France and internationally. More details

0RAF fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	2/6
Dividends	0/6

Rewards

Became profitable this year

Risk Analysis

Interest payments are not well covered by earnings

Shares are highly illiquid

Large one-off items impacting financial results

My Notes

Capture your thoughts, links and company narrative

Amplitude Surgical SA Competitors

EKF Diagnostics Holdings

AIM:EKF

UK£120.7m

NIOX Group

AIM:NIOX

UK£238.8m

Tristel

AIM:TSTL

UK£202.7m

Smith & Nephew

LSE:SN.

UK£8.6b

Price History & Performance

Summary of share price highs, lows and changes for Amplitude Surgical
Historical stock prices
Current Share Price	€3.36
52 Week High	€3.36
52 Week Low	€3.36
Beta	0.49
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	99.41%
Change since IPO	-28.05%

Recent updates

Shareholder Returns

	0RAF	GB Medical Equipment	GB Market
7D	0%	-0.2%	0.6%
1Y	n/a	-10.7%	4.6%

Return vs Industry: Insufficient data to determine how 0RAF performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how 0RAF performed against the UK Market.

Price Volatility

Is 0RAF's price volatile compared to industry and market?
0RAF volatility
0RAF Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.6%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.6%
10% least volatile stocks in GB Market	2.5%

Stable Share Price: 0RAF's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0RAF's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1997	389	Olivier Jallabert	www.amplitude-surgical.com

Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical SA Fundamentals Summary

How do Amplitude Surgical's earnings and revenue compare to its market cap?
0RAF fundamental statistics
Market cap	€153.51m
Earnings (TTM)	€1.53m
Revenue (TTM)	€106.02m

100.5x

P/E Ratio

1.4x

P/S Ratio

Is 0RAF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0RAF income statement (TTM)
Revenue	€106.02m
Cost of Revenue	€51.77m
Gross Profit	€54.25m
Other Expenses	€52.72m
Earnings	€1.53m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 26, 2025

Earnings per share (EPS)	0.032
Gross Margin	51.17%
Net Profit Margin	1.44%
Debt/Equity Ratio	110.9%

How did 0RAF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 22:41
End of Day Share Price	2024/11/27 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amplitude Surgical SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Lionel Labourdette	Kepler Cheuvreux
Stephane Sumar	Natixis S.A.
Christophe-Raphael Ganet	ODDO BHF Corporate & Markets